Aztreonam-Avibactam: Clinical Trials

6 trials of Aztreonam-Avibactam, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 1 enrolling by invitation, 1 not yet recruiting. 2 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 31Not yet recruiting 1

Follow Aztreonam-Avibactam: new trials by email Literature Review of Aztreonam-Avibactam trials Research Report on Aztreonam-Avibactam

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Aztreonam-Avibactam in Immunocompromised Hosts
Aztreonam-Avibactam, Ceftazidime-Avibactam Plus Aztreonam - Enterobacteriaceae Infections, Carbapenem-Resistant Enterobacteriaceae Infection
RecruitingCentro de Educación Medica e Investigaciones Clínicas Norberto Quirno8142026-10-142026-10-22
Targeted Versus Standard Peri-operative Antibiotic Prophylaxis in Patients Colonized With Carbapenemase Producing Enterobacterales Undergoing Liver Transplantation
Ceftazidime - Avibactam ( CAZ-AVI), Meropenem-Vaborbactam, Imipenem+Relebactam - Liver Transplant, Carbapenem-resistant Enterobacterales
Phase 3Not yet recruitingIRCCS Azienda Ospedaliero-Universitaria di Bologna1682026-10-012026-08-12
Real-World Effectiveness of Aztreonam-Avibactam Against MBL-Producing CRE
Aztreonam-Avibactam - Complicated Intra-Abdominal Infections, cIAIs, Hospital-acquired Pneumonia (HAP)
RecruitingSir Run Run Shaw Hospital1002025-12-252026-03-23
Real-world Multicentre Study of AZtreonam-AVIbactam Treatment With Infections or Suspected Infections Caused by Multidrug-resistant Gram-negative Bacteria
Aztreonam-Avibactam - Critical Care, Infection
Enrolling by invitationFrench Society for Intensive Care1002024-01-012025-09-16
Study to Assess the Pharmacokinetics, Safety and Tolerability of Aztreonam-Avibactam in Healthy Chinese Participants.
Aztreonam-Avibactam - Healthy
Phase 1CompletedPfizer122021-08-202023-07-28
Pharmacokinetic Study of Aztreonam-Avibactam in Severe Renal Impairment
Aztreonam-Avibactam - Renal Insufficiency
Phase 1CompletedPfizer112020-08-102023-07-28

Conditions studied

Infections (2)  ·  Communicable Diseases (1)  ·  Enterobacteriaceae Infections (1)  ·  Healthcare-Associated Pneumonia (1)  ·  Pneumonia, Ventilator-Associated (1)  ·  Renal Insufficiency (1)

Sponsors

Pfizer (2)  ·  Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno (1)  ·  French Society for Intensive Care (1)  ·  IRCCS Azienda Ospedaliero-Universitaria di Bologna (1)  ·  Sir Run Run Shaw Hospital (1)

Countries

China (2)  ·  Argentina (1)  ·  France (1)  ·  Italy (1)  ·  United States (1)

Top investigators

Diego Torres, MD (1)  ·  Maddalena Giannella, MD, PhD (1)  ·  Maximiliano Gabriel Castro, MD (1)

Results publications

PMID 41709845

NIH funding

2025 (1)